Dissecting the roles of miR-140 and its host gene
To the editor -The functional coherence between microRNAs (miRNAs) and their host genes remains enigmatic. As host genes and their intron-derived miRNAs are transcribed as cistronic units, their functional coherence could be beneficial for the organism. Indeed, several intronic miRNAs are reported to act coherently with their host genes for processes such as muscle fibre-type selection or cholesterol metabolism 1, 2 . However, it is not clear how broadly that coherence takes place in an organism. Previously, we and others have reported that targeted deletion of a chondrocyte-specific miRNA, miR-140, caused craniofacial truncation due to impaired chondrocyte differentiation 3, 4 . miR-140 regulates several target genes, including Adamts-5 and Dnpep, and in turn governs the proliferation and differentiation of chondrocytes 3, 4 . Interestingly, ubiquitin E3 ligase Wwp2, the host gene of miR-140, knockout (KO) mice were subsequently reported in Nature Cell Biology (Wwp2 GT/GT mouse) with a similar craniofacial truncation phenotype 5 . In this report, Zou et al. demonstrated that Wwp2 mono-ubiquitylates the transcription factor Goosecoid, and this modification is indispensable for transcription of Sox6 (a key transcription factor for chondrocyte differentiation) and thus Wwp2 GT/GT mice displayed the craniofacial phenotype due to cartilage malformation 5 . These reports suggested an intriguing possibility that miR-140 and its host gene, Wwp2, have overlapping or coherent functions in craniofacial morphogenesis. At the same time, the methodology to generate the Wwp2 GT allele -insertion of a gene-trap cassette into the third intron of the Wwp2 gene 5 -attracted our attention (Fig. 1a) . The gene-trap cassette prevents expression of exons and introns downstream of its insertion site, and indeed Zou et al. showed that the Wwp2 transcript that corresponded to downstream exons were absent from their KO mice 5 . As such, miR-140, which is encoded further downstream, might also be downregulated in these mice (Fig. 2a) . In this scenario, the craniofacial phenotype observed in Wwp2 GT/GT mice might be, in part, caused by the loss of miR-140.
To explore these two possibilities, we took advantage of the CRISPR-Cas9 system to generate miR-140 and Wwp2 KO mice, and miR-140/Wwp2 double-KO mice. Single-guide (sg)RNAs, which target the second exon of the Wwp2 gene and/or the . Expression levels of miR-140 are normalized with those of RNU6B (left panel) or snoRNA135 (right panel). mut., mutant; a.u., arbitrary unit. Statistical analysis: two-tailed two-sample student t-test, n= 3 (independent animals) for WT (left panel) and miR-140 14del, n= 4 (independent animals) for WT (right panel) and miR-140 132del. Box plots show median and 25-75th percentiles (middle line and box, respectively). Whiskers extend to the maximum and minimum data points. e, Western blot analysis of Wwp2 protein in the chondrocytes of newborn mice. Anti-Wwp2 and anti-AIP2 antibodies detect the same protein (Wwp2) with distinct epitopes. GAPDH serves as a loading control. 1del, Wwp2 (Fig. 1b,c) . Western blot and quantitative polymerase chain reaction (qPCR) analyses confirmed that no Wwp2 protein was detected in the chondrocytes of mice with mutated Wwp2 alleles (Fig. 1e ) and mature miR-140 was absent in chondrocytes of mice with mutated miR-140 alleles (Fig. 1d) , respectively. Next, we examined the craniofacial phenotype of these mice. The skulls of 30-day-old mice were observed with microcomputed topography (CT) (Fig. 1f) . First, we confirmed that the skulls of miR-140 KO mice were truncated as in the previous report (Fig. 1f) . However, to our surprise, the skulls of Wwp2 KO mice were undistinguishable from that of wild-type (WT) mice (Fig. 1f) . The miR-140/Wwp2 double-KO mice had truncated skulls, but no apparent difference was seen when compared with the miR-140 KO skull (Fig. 1f) . These results suggest that, at least in our system, the loss of Wwp2 protein alone does not cause the craniofacial truncation phenotype. Furthermore, simultaneous depletion of Wwp2 protein and miR-140 does not promote the craniofacial phenotype caused by loss of miR-140 (Fig. 1f) . In summary, our results suggest that skull truncation correlates with loss of miR-140 expression, but not with Wwp2 protein level, and that the functional coherence between these two factors does not take place during craniofacial skeletal development. Our results also suggested that the craniofacial phenotype observed in Wwp2 GT/GT mice was not due to the loss of Wwp2 protein, but to the unintentional loss of miR-140 expression by the genetrap cassette. Consistent with this idea, not only Wwp2 protein but also miR-140 are significantly reduced with the Wwp2 GT allele (Fig. 2b,c) (Fig. 2a) ; miR-140 GT/+ ) showed no craniofacial phenotype with no Wwp2 protein and reduced but significant miR-140 expression (Fig. 2b-d) , compound heterozygotes of Wwp2
GT and miR-140 KO 
(Wwp2

GT/+
; miR-140 GT/14del ) showed clear craniofacial truncation with reduced but significant Wwp2 protein and no miR-140 expression (Fig. 2b-d) . These results demonstrated that craniofacial truncation appeared when expression of miR-140, but not Wwp2, was depleted from the allele combined with Wwp2
GT
. From these results, we concluded that miR-140, not Wwp2 protein is required for proper craniofacial development.
The host-miRNA relationship between Wwp2 and miR-140 is evolutionarily conserved among vertebrates, and miR-140 and Wwp2 are highly expressed in embryonic and adult chondrocytes in both zebrafish and mouse [6] [7] [8] . Moreover, loss of miR-140 and Wwp2 are linked with palatogenesis in zebrafish 8, 9 . Therefore, although we did not find cooperative function between miR-140 and Wwp2 in craniofacial development in mice, it remains an attractive possibility that these two factors cooperate in other contexts in mammals, such as cartilage homeostasis or the pathogenic processes of osteoarthritis, rheumatoid arthritis and other diseases.
Gene-trap is a powerful genetic screen tool to identify KO mice with phenotypes of interest, assuming that the gene-trap cassette blocks expression of a protein coding gene 10 . However, our results imply that we should be cautious when evaluating the phenotypes of KO mice generated by gene-trap or similar strategies, as they may also affect expression of downstream elements of the targeted protein coding genes, such as miRNAs.
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